Set as Homepage - Bookmark This Page   
You are here:Home >Spotlight >Waters... noitazilaicremmoC dna tnempole Content

Waters... noitazilaicremmoC dna tnempole

Source: Editor: SpotlightDate: 2025-06-14 09:52:58
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists

2.2789s , 6837.2265625 kb

Copyright © 2025 Powered by Waters... noitazilaicremmoC dna tnempole,  

sitemap

Top